Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.

Shevalye H, Watcho P, Stavniichuk R, Dyukova E, Lupachyk S, Obrosova IG.

Diabetes. 2012 Aug;61(8):2126-33. doi: 10.2337/db11-1524. Epub 2012 Jun 29.

2.

Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.

Vareniuk I, Pacher P, Pavlov IA, Drel VR, Obrosova IG.

Int J Mol Med. 2009 May;23(5):571-80.

3.

Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Stavniichuk R, Drel VR, Shevalye H, Maksimchyk Y, Kuchmerovska TM, Nadler JL, Obrosova IG.

Exp Neurol. 2011 Jul;230(1):106-13. doi: 10.1016/j.expneurol.2011.04.002. Epub 2011 Apr 16.

4.

Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.

Fonseca VA, Lavery LA, Thethi TK, Daoud Y, DeSouza C, Ovalle F, Denham DS, Bottiglieri T, Sheehan P, Rosenstock J.

Am J Med. 2013 Feb;126(2):141-9. doi: 10.1016/j.amjmed.2012.06.022. Epub 2012 Dec 5.

PMID:
23218892
5.

Metanx and early stages of diabetic retinopathy.

Liu H, Tang J, Lee CA, Kern TS.

Invest Ophthalmol Vis Sci. 2015 Jan 8;56(1):647-53. doi: 10.1167/iovs.14-15220.

6.

Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.

Lupachyk S, Watcho P, Shevalye H, Vareniuk I, Obrosov A, Obrosova IG, Yorek MA.

Am J Physiol Endocrinol Metab. 2013 Aug 1;305(3):E396-404. doi: 10.1152/ajpendo.00186.2013. Epub 2013 Jun 4.

7.

Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA.

Diabetes Obes Metab. 2009 Mar;11(3):223-33. doi: 10.1111/j.1463-1326.2008.00924.x. Epub 2008 Jun 16.

8.

A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

Drel VR, Pacher P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov VV, Tibrewala J, Groves JT, Obrosova IG.

Eur J Pharmacol. 2007 Aug 13;569(1-2):48-58. Epub 2007 Jun 9.

9.

Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

Vareniuk I, Pavlov IA, Drel VR, Lyzogubov VV, Ilnytska O, Bell SR, Tibrewala J, Groves JT, Obrosova IG.

Exp Neurol. 2007 Jun;205(2):425-36. Epub 2007 Mar 27.

PMID:
17475250
10.

The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.

Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG.

Diabetes. 2006 Dec;55(12):3335-43.

11.

Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.

Sugimoto K, Kojima K, Baba M, Yasujima M.

J Hypertens. 2011 Jul;29(7):1337-46. doi: 10.1097/HJH.0b013e328347da0f.

PMID:
21602711
12.

The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.

Shimoshige Y, Ikuma K, Yamamoto T, Takakura S, Kawamura I, Seki J, Mutoh S, Goto T.

Metabolism. 2000 Nov;49(11):1395-9.

PMID:
11092500
13.

Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.

Davidson EP, Holmes A, Coppey LJ, Yorek MA.

Eur J Pharmacol. 2015 Oct 15;765:258-67. doi: 10.1016/j.ejphar.2015.08.015. Epub 2015 Aug 18.

PMID:
26291662
14.

Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.

Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, Yorek MA.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. Epub 2007 Oct 2.

15.

Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Vareniuk I, Pavlov IA, Obrosova IG.

Diabetologia. 2008 Nov;51(11):2126-33. doi: 10.1007/s00125-008-1136-3. Epub 2008 Sep 19.

17.

Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.

Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.

Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):49-56.

PMID:
11921418
18.

A medicinal food provides food for thought in managing diabetic neuropathy.

Vinik AI.

Am J Med. 2013 Feb;126(2):95-6. doi: 10.1016/j.amjmed.2012.08.008. No abstract available.

PMID:
23331432
19.

Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.

Davidson EP, Coppey LJ, Holmes A, Lupachyk S, Dake BL, Oltman CL, Peterson RG, Yorek MA.

J Diabetes Res. 2014;2014:714273. doi: 10.1155/2014/714273. Epub 2014 Oct 13.

20.

Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.

Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E113-22. Epub 2005 Feb 22.

Supplemental Content

Support Center